{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:14:49Z","timestamp":1789161289772,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Estrogen receptor-positive (ER+) breast cancer is the predominant subtype of breast cancer, and its development is closely linked to metabolic reprogramming, including alterations in cholesterol metabolism. Therefore, this study aimed to investigate the functional interplay between lysine demethylase 5B (KDM5B) and the Cullin-RING ligase 4B (CRL4B) complex in modulating cholesterol metabolism to promote ER+ breast cancer progression. Immunohistochemical assays and bioinformatic analysis of various cancer databases were performed to examine KDM5B expression levels in breast cancer. Additionally, KDM5B overexpression and knockdown were performed to investigate the role of KDM5B in breast cancer cell proliferation and progression. Notably, we identified physical and functional interactions between KDM5B and the CRL4B subunits, CUL4B and DDB1. Mechanistically, KDM5B recruits CRL4B to the promoters of INSIG1 and INSIG2, which are key regulators of cholesterol biosynthesis and uptake, and suppresses their expression by upregulating H2AK119ub1 and downregulating H3K4me3 histone marks, thereby promoting the proliferation, migration, and invasion of tumor cells. Functional assays revealed that disruption of the KDM5B\u2013CRL4B axis impairs cholesterol homeostasis and inhibits tumor growth. KDM5B upregulation was significantly negatively correlated with the survival rates in various cancer types, including thyroid, lung, esophageal and colorectal cancers. Overall, these findings establish a novel regulatory axis in cholesterol metabolism, uncover potential therapeutic vulnerabilities in ER+ breast cancer, and suggest that targeting the KDM5B could provide a strategy to curb tumor progression.<\/jats:p>","DOI":"10.1038\/s41419-026-08438-1","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T06:34:08Z","timestamp":1770446048000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["KDM5B cooperates with CRL4B complex to promote the tumorigenesis of ER+ breast cancer via regulating cholesterol metabolism"],"prefix":"10.1038","volume":"17","author":[{"given":"Yunkai","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baowen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhui","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Die","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hefen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8714-4757","authenticated-orcid":false,"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2854-5446","authenticated-orcid":false,"given":"Jingyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2563-255X","authenticated-orcid":false,"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"key":"8438_CR1","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s13238-014-0078-4","volume":"5","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Yang H, Guo X, Rong N, Song Y, Xu Y, et al. The PHD1 finger of KDM5B recognizes unmodified H3K4 during the demethylation of histone H3K4me2\/3 by KDM5B. Protein Cell. 2014;5:837\u201350.","journal-title":"Protein Cell"},{"key":"8438_CR2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nrm3327","volume":"13","author":"SM Kooistra","year":"2012","unstructured":"Kooistra SM, Helin K. Molecular mechanisms and potential functions of histone demethylases. Nat Rev Mol Cell Biol. 2012;13:297\u2013311.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8438_CR3","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.3390\/cancers14133270","volume":"14","author":"Y Ohguchi","year":"2022","unstructured":"Ohguchi Y, Ohguchi H. Diverse functions of KDM5 in cancer: transcriptional repressor or activator? Cancers. 2022;14:3270.","journal-title":"Cancers"},{"key":"8438_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/bies.201600095","volume":"39","author":"FS Howe","year":"2017","unstructured":"Howe FS, Fischl H, Murray SC, Mellor J. Is H3K4me3 instructive for transcription activation? Bioessays. 2017;39:1\u201312.","journal-title":"Bioessays"},{"key":"8438_CR5","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1038\/s41594-020-00513-1","volume":"27","author":"S Wang","year":"2020","unstructured":"Wang S, Meyer DH, Schumacher B. H3K4me2 regulates the recovery of protein biosynthesis and homeostasis following DNA damage. Nat Struct Mol Biol. 2020;27:1165\u201377.","journal-title":"Nat Struct Mol Biol"},{"key":"8438_CR6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.chembiol.2017.02.006","volume":"24","author":"A Tumber","year":"2017","unstructured":"Tumber A, Nuzzi A, Hookway ES, Hatch SB, Velupillai S, Johansson C, et al. Potent and selective KDM5 inhibitor stops cellular demethylation of H3K4me3 at transcription start sites and proliferation of MM1S myeloma cells. Cell Chem Biol. 2017;24:371\u201380.","journal-title":"Cell Chem Biol"},{"key":"8438_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mrrev.2017.09.003","volume":"780","author":"F Gong","year":"2019","unstructured":"Gong F, Miller KM. Histone methylation and the DNA damage response. Mutat Res Rev Mutat Res. 2019;780:37\u201347.","journal-title":"Mutat Res Rev Mutat Res"},{"key":"8438_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.nlm.2019.04.009","volume":"161","author":"BE Collins","year":"2019","unstructured":"Collins BE, Sweatt JD, Greer CB. Broad domains of histone 3 lysine 4 trimethylation are associated with transcriptional activation in CA1 neurons of the hippocampus during memory formation. Neurobiol Learn Mem. 2019;161:149\u201357.","journal-title":"Neurobiol Learn Mem"},{"key":"8438_CR9","doi-asserted-by":"crossref","unstructured":"Wang, H, & Helin, K Roles of H3K4 methylation in biology and disease. Trends Cell Biol. 2024;35:115\u201328.","DOI":"10.1016\/j.tcb.2024.06.001"},{"key":"8438_CR10","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1038\/s41388-022-02311-z","volume":"41","author":"R He","year":"2022","unstructured":"He R, Xhabija B, Gopi LK, Kurup JT, Xu Z, Liu Z, et al. H3K4 demethylase KDM5B regulates cancer cell identity and epigenetic plasticity. Oncogene. 2022;41:2958\u201372.","journal-title":"Oncogene"},{"key":"8438_CR11","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1038\/s12276-022-00902-0","volume":"54","author":"J Yoo","year":"2022","unstructured":"Yoo J, Kim GW, Jeon YH, Kim JY, Lee SW, Kwon SH. Drawing a line between histone demethylase KDM5A and KDM5B: their roles in development and tumorigenesis. Exp Mol Med. 2022;54:2107\u201317.","journal-title":"Exp Mol Med"},{"key":"8438_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02011-0","volume":"23","author":"CY Li","year":"2024","unstructured":"Li CY, Wang W, Leung CH, Yang GJ, Chen J. KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges. Mol Cancer. 2024;23:109.","journal-title":"Mol Cancer"},{"key":"8438_CR13","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.ccr.2014.04.024","volume":"25","author":"S Yamamoto","year":"2014","unstructured":"Yamamoto S, Wu Z, Russnes HG, Takagi S, Peluffo G, Vaske C, et al. JARID1B is a luminal lineage-driving oncogene in breast cancer. Cancer Cell. 2014;25:762\u201377.","journal-title":"Cancer Cell"},{"key":"8438_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112760","volume":"208","author":"YD Fu","year":"2020","unstructured":"Fu YD, Huang MJ, Guo JW, You YZ, Liu HM, Huang LH, et al. Targeting histone demethylase KDM5B for cancer treatment. Eur J Med Chem. 2020;208:112760.","journal-title":"Eur J Med Chem"},{"key":"8438_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ejmech.2018.10.040","volume":"161","author":"YC Zheng","year":"2019","unstructured":"Zheng YC, Chang J, Wang LC, Ren HM, Pang JR, Liu HM. Lysine demethylase 5B (KDM5B): a potential anti-cancer drug target. Eur J Med Chem. 2019;161:131\u201340.","journal-title":"Eur J Med Chem"},{"key":"8438_CR16","doi-asserted-by":"crossref","unstructured":"Jose A, Shenoy GG, Sunil Rodrigues G, Kumar NAN, Munisamy M, Thomas L et al. Histone demethylase KDM5B as a therapeutic target for cancer therapy. Cancers. 2020;12:2121.","DOI":"10.3390\/cancers12082121"},{"key":"8438_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114991","volume":"43","author":"B DiCiaccio","year":"2024","unstructured":"DiCiaccio B, Seehawer M, Li Z, Patmanidis A, Bui T, Foidart P, et al. ZBTB7A is a modulator of KDM5-driven transcriptional networks in basal breast cancer. Cell Rep. 2024;43:114991.","journal-title":"Cell Rep"},{"key":"8438_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.celrep.2013.12.021","volume":"6","author":"BJ Klein","year":"2014","unstructured":"Klein BJ, Piao L, Xi Y, Rincon-Arano H, Rothbart SB, Peng D, et al. The histone-H3K4-specific demethylase KDM5B binds to its substrate and product through distinct PHD fingers. Cell Rep. 2014;6:325\u201335.","journal-title":"Cell Rep"},{"key":"8438_CR19","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/s41418-023-01155-8","volume":"30","author":"L Qin","year":"2023","unstructured":"Qin L, Song Y, Zhang F, Wang R, Zhou L, Jin S, et al. CRL4B complex-mediated H2AK119 monoubiquitination restrains Th1 and Th2 cell differentiation. Cell Death Differ. 2023;30:1488\u2013502.","journal-title":"Cell Death Differ"},{"key":"8438_CR20","first-page":"4679","volume":"127","author":"Q Ji","year":"2014","unstructured":"Ji Q, Hu H, Yang F, Yuan J, Yang Y, Jiang L, et al. CRL4B interacts with and coordinates the SIN3A-HDAC complex to repress CDKN1A and drive cell cycle progression. J Cell Sci. 2014;127:4679\u201391.","journal-title":"J Cell Sci"},{"key":"8438_CR21","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1038\/s41418-021-00821-z","volume":"28","author":"S Leng","year":"2021","unstructured":"Leng S, Huang W, Chen Y, Yang Y, Feng D, Liu W, et al. SIRT1 coordinates with the CRL4B complex to regulate pancreatic cancer stem cells to promote tumorigenesis. Cell Death Differ. 2021;28:3329\u201343.","journal-title":"Cell Death Differ"},{"key":"8438_CR22","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.ccr.2012.10.024","volume":"22","author":"H Hu","year":"2012","unstructured":"Hu H, Yang Y, Ji Q, Zhao W, Jiang B, Liu R, et al. CRL4B catalyzes H2AK119 monoubiquitination and coordinates with PRC2 to promote tumorigenesis. Cancer Cell. 2012;22:781\u201395.","journal-title":"Cancer Cell"},{"key":"8438_CR23","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1038\/s41418-022-01010-2","volume":"29","author":"X Yin","year":"2022","unstructured":"Yin X, Teng X, Ma T, Yang T, Zhang J, Huo M, et al. RUNX2 recruits the NuRD(MTA1)\/CRL4B complex to promote breast cancer progression and bone metastasis. Cell Death Differ. 2022;29:2203\u201317.","journal-title":"Cell Death Differ"},{"key":"8438_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202202737","volume":"10","author":"T Yang","year":"2023","unstructured":"Yang T, Huang W, Ma T, Yin X, Zhang J, Huo M, et al. The PRMT6\/PARP1\/CRL4B complex regulates the circadian clock and promotes breast tumorigenesis. Adv Sci. 2023;10:e2202737.","journal-title":"Adv Sci"},{"key":"8438_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"8438_CR26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","volume":"21","author":"J Luo","year":"2020","unstructured":"Luo J, Yang H, Song BL. Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol. 2020;21:225\u201345.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8438_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25354-4","volume":"12","author":"W Liu","year":"2021","unstructured":"Liu W, Chakraborty B, Safi R, Kazmin D, Chang CY, McDonnell DP. Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer. Nat Commun. 2021;12:5103.","journal-title":"Nat Commun"},{"key":"8438_CR28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.celrep.2013.10.006","volume":"5","author":"Q Wu","year":"2013","unstructured":"Wu Q, Ishikawa T, Sirianni R, Tang H, McDonald JG, Yuhanna IS, et al. 27-hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth. Cell Rep. 2013;5:637\u201345.","journal-title":"Cell Rep"},{"key":"8438_CR29","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1126\/science.1241908","volume":"342","author":"ER Nelson","year":"2013","unstructured":"Nelson ER, Wardell SE, Jasper JS, Park S, Suchindran S, Howe MK, et al. 27-hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology. Science. 2013;342:1094\u20138.","journal-title":"Science"},{"key":"8438_CR30","doi-asserted-by":"publisher","first-page":"102643","DOI":"10.1016\/j.redox.2023.102643","volume":"61","author":"L Goicoechea","year":"2023","unstructured":"Goicoechea L, Conde de la Rosa L, Torres S, Garc\u00eda-Ruiz C, Fern\u00e1ndez-Checa JC. Mitochondrial cholesterol: metabolism and impact on redox biology and disease. Redox Biol. 2023;61:102643.","journal-title":"Redox Biol"},{"key":"8438_CR31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fgene.2014.00311","volume":"5","author":"S Meaney","year":"2014","unstructured":"Meaney S. Epigenetic regulation of cholesterol homeostasis. Front Genet. 2014;5:311.","journal-title":"Front Genet"},{"key":"8438_CR32","first-page":"1267","volume":"38","author":"S Catchpole","year":"2011","unstructured":"Catchpole S, Spencer-Dene B, Hall D, Santangelo S, Rosewell I, Guenatri M, et al. PLU-1\/JARID1B\/KDM5B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ breast cancer cells. Int J Oncol. 2011;38:1267\u201377.","journal-title":"Int J Oncol"},{"key":"8438_CR33","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.tcb.2020.07.003","volume":"30","author":"B Bakir","year":"2020","unstructured":"Bakir B, Chiarella AM, Pitarresi JR, Rustgi AK. EMT, MET, plasticity, and tumor metastasis. Trends Cell Biol. 2020;30:764\u201376.","journal-title":"Trends Cell Biol"},{"key":"8438_CR34","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1182\/blood-2014-08-596734","volume":"125","author":"MH Stewart","year":"2015","unstructured":"Stewart MH, Albert M, Sroczynska P, Cruickshank VA, Guo Y, Rossi DJ, et al. The histone demethylase Jarid1b is required for hematopoietic stem cell self-renewal in mice. Blood. 2015;125:2075\u20138.","journal-title":"Blood"},{"key":"8438_CR35","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1182\/blood-2013-04-496281","volume":"122","author":"S Cellot","year":"2013","unstructured":"Cellot S, Hope KJ, Chagraoui J, Sauvageau M, Deneault \u00c9, MacRae T, et al. RNAi screen identifies Jarid1b as a major regulator of mouse HSC activity. Blood. 2013;122:1545\u201355.","journal-title":"Blood"},{"key":"8438_CR36","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.cell.2009.05.050","volume":"138","author":"Y Wang","year":"2009","unstructured":"Wang Y, Zhang H, Chen Y, Sun Y, Yang F, Yu W, et al. LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell. 2009;138:660\u201372.","journal-title":"Cell"},{"key":"8438_CR37","doi-asserted-by":"publisher","first-page":"e2122940119","DOI":"10.1073\/pnas.2122940119","volume":"119","author":"Z Ren","year":"2022","unstructured":"Ren Z, Kim A, Huang YT, Pi WC, Gong W, Yu X, et al. A PRC2-Kdm5b axis sustains tumorigenicity of acute myeloid leukemia. Proc Natl Acad Sci USA. 2022;119:e2122940119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8438_CR38","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/nature17416","volume":"531","author":"S Cavadini","year":"2016","unstructured":"Cavadini S, Fischer ES, Bunker RD, Potenza A, Lingaraju GM, Goldie KN, et al. Cullin-RING ubiquitin E3 ligase regulation by the COP9 signalosome. Nature. 2016;531:598\u2013603.","journal-title":"Nature"},{"key":"8438_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn5295","volume":"8","author":"M Luo","year":"2022","unstructured":"Luo M, Bao L, Chen Y, Xue Y, Wang Y, Zhang B, et al. ZMYND8 is a master regulator of 27-hydroxycholesterol that promotes tumorigenicity of breast cancer stem cells. Sci Adv. 2022;8:eabn5295.","journal-title":"Sci Adv"},{"key":"8438_CR40","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.ccell.2018.10.014","volume":"34","author":"K Hinohara","year":"2018","unstructured":"Hinohara K, Wu HJ, Vigneau S, McDonald TO, Igarashi KJ, Yamamoto KN, et al. KDM5 histone demethylase activity links cellular transcriptomic heterogeneity to therapeutic resistance. Cancer Cell. 2018;34:939\u2013953.e939.","journal-title":"Cancer Cell"},{"key":"8438_CR41","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.canlet.2015.07.003","volume":"368","author":"CS Lin","year":"2015","unstructured":"Lin CS, Lin YC, Adebayo BO, Wu A, Chen JH, Peng YJ, et al. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma. Cancer Lett. 2015;368:36\u201345.","journal-title":"Cancer Lett"},{"key":"8438_CR42","doi-asserted-by":"publisher","first-page":"5538","DOI":"10.1158\/0008-5472.CAN-15-3377","volume":"76","author":"ND Facompre","year":"2016","unstructured":"Facompre ND, Harmeyer KM, Sole X, Kabraji S, Belden Z, Sahu V, et al. JARID1B enables transit between distinct states of the stem-like cell population in oral cancers. Cancer Res. 2016;76:5538\u201349.","journal-title":"Cancer Res"},{"key":"8438_CR43","doi-asserted-by":"publisher","first-page":"19226","DOI":"10.1073\/pnas.0700735104","volume":"104","author":"Y Xiang","year":"2007","unstructured":"Xiang Y, Zhu Z, Han G, Ye X, Xu B, Peng Z, et al. JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer. Proc Natl Acad Sci USA. 2007;104:19226\u201331.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8438_CR44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13046-016-0311-5","volume":"35","author":"D Wang","year":"2016","unstructured":"Wang D, Han S, Peng R, Jiao C, Wang X, Yang X, et al. Depletion of histone demethylase KDM5B inhibits cell proliferation of hepatocellular carcinoma by regulation of cell cycle checkpoint proteins p15 and p27. J Exp Clin Cancer Res. 2016;35:37.","journal-title":"J Exp Clin Cancer Res"},{"key":"8438_CR45","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cell.2016.02.064","volume":"165","author":"H Shen","year":"2016","unstructured":"Shen H, Xu W, Guo R, Rong B, Gu L, Wang Z, et al. Suppression of enhancer overactivation by a RACK7-histone demethylase complex. Cell. 2016;165:331\u201342.","journal-title":"Cell"},{"key":"8438_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202004635","volume":"8","author":"HF Shen","year":"2021","unstructured":"Shen HF, Zhang WJ, Huang Y, He YH, Hu GS, Wang L, et al. The dual function of KDM5C in both gene transcriptional activation and repression promotes breast cancer cell growth and tumorigenesis. Adv Sci (Weinh). 2021;8:2004635.","journal-title":"Adv Sci (Weinh)"},{"key":"8438_CR47","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41586-021-03994-2","volume":"598","author":"SM Zhang","year":"2021","unstructured":"Zhang SM, Cai WL, Liu X, Thakral D, Luo J, Chan LH, et al. KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements. Nature. 2021;598:682\u20137.","journal-title":"Nature"},{"key":"8438_CR48","doi-asserted-by":"publisher","first-page":"e2006134","DOI":"10.1371\/journal.pbio.2006134","volume":"16","author":"L Wu","year":"2018","unstructured":"Wu L, Cao J, Cai WL, Lang SM, Horton JR, Jansen DJ, et al. KDM5 histone demethylases repress immune response via suppression of STING. PLoS Biol. 2018;16:e2006134.","journal-title":"PLoS Biol"},{"key":"8438_CR49","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1158\/0008-5472.CAN-20-0505","volume":"80","author":"G Li","year":"2020","unstructured":"Li G, Kanagasabai T, Lu W, Zou MR, Zhang SM, Celada SI, et al. KDM5B is essential for the hyperactivation of PI3K\/AKT signaling in prostate tumorigenesis. Cancer Res. 2020;80:4633\u201343.","journal-title":"Cancer Res"},{"key":"8438_CR50","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1074\/jbc.M115.698449","volume":"291","author":"JR Horton","year":"2016","unstructured":"Horton JR, Engstrom A, Zoeller EL, Liu X, Shanks JR, Zhang X, et al. Characterization of a linked jumonji domain of the KDM5\/JARID1 family of histone H3 lysine 4 demethylases. J Biol Chem. 2016;291:2631\u201346.","journal-title":"J Biol Chem"},{"key":"8438_CR51","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","volume":"2","author":"B Huang","year":"2020","unstructured":"Huang B, Song BL, Xu C. Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities. Nat Metab. 2020;2:132\u201341.","journal-title":"Nat Metab"},{"key":"8438_CR52","doi-asserted-by":"publisher","first-page":"E9346","DOI":"10.1073\/pnas.1707965114","volume":"114","author":"M Voisin","year":"2017","unstructured":"Voisin M, de Medina P, Mallinger A, Dalenc F, Huc-Claustre E, Leignadier J, et al. Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor. Proc Natl Acad Sci USA. 2017;114:E9346\u2013e9355.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8438_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04236-x","volume":"21","author":"S Ning","year":"2023","unstructured":"Ning S, Liu C, Wang K, Cai Y, Ning Z, Li M, et al. NUCB2\/Nesfatin-1 drives breast cancer metastasis through the up-regulation of cholesterol synthesis via the mTORC1 pathway. J Transl Med. 2023;21:362.","journal-title":"J Transl Med"},{"key":"8438_CR54","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/nm1641","volume":"13","author":"M Umetani","year":"2007","unstructured":"Umetani M, Domoto H, Gormley AK, Yuhanna IS, Cummins CL, Javitt NB, et al. 27-hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat Med. 2007;13:1185\u201392.","journal-title":"Nat Med"},{"key":"8438_CR55","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1210\/me.2007-0383","volume":"22","author":"CD DuSell","year":"2008","unstructured":"DuSell CD, Umetani M, Shaul PW, Mangelsdorf DJ, McDonnell DP. 27-hydroxycholesterol is an endogenous selective estrogen receptor modulator. Mol Endocrinol. 2008;22:65\u201377.","journal-title":"Mol Endocrinol"},{"key":"8438_CR56","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.mce.2017.09.021","volume":"466","author":"ER Nelson","year":"2018","unstructured":"Nelson ER. The significance of cholesterol and its metabolite, 27-hydroxycholesterol in breast cancer. Mol Cell Endocrinol. 2018;466:73\u201380.","journal-title":"Mol Cell Endocrinol"},{"key":"8438_CR57","first-page":"3007","volume":"32","author":"A El Roz","year":"2012","unstructured":"El Roz A, Bard JM, Huvelin JM, Nazih H. LXR agonists and ABCG1-dependent cholesterol efflux in MCF-7 breast cancer cells: relation to proliferation and apoptosis. Anticancer Res. 2012;32:3007\u201313.","journal-title":"Anticancer Res"},{"key":"8438_CR58","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1124\/mol.117.110742","volume":"93","author":"M Lam","year":"2018","unstructured":"Lam M, Mast N, Pikuleva IA. Drugs and scaffold that inhibit cytochrome P450 27A1 in vitro and in vivo. Mol Pharmacol. 2018;93:101\u20138.","journal-title":"Mol Pharmacol"},{"key":"8438_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00910-z","volume":"8","author":"AE Baek","year":"2017","unstructured":"Baek AE, Yu YA, He S, Wardell SE, Chang CY, Kwon S, et al. The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells. Nat Commun. 2017;8:864.","journal-title":"Nat Commun"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08438-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08438-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08438-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:03:19Z","timestamp":1770822199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08438-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8438"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08438-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Animal handling and procedures were approved by the Experimental Animal Ethics Committee of the Institute of Cancer, Cancer Hospital, Chinese Academy of Medical Sciences (NCC2021A285).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"207"}}